Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Meningococcal B Vaccine and Meningococcal Carriage in Adolescents in Australia

22 Jan 2020

Abstract excerpt

BACKGROUND: The meningococcal group B vaccine 4CMenB is a new, recombinant protein-based vaccine that is licensed to protect against invasive group B meningococcal disease. However, its role in preventing transmission and, therefore, inducing population (herd) protection is uncertain. METHODS: and individual disease-causing genogroups. Risk factors for carriage were assessed at baseline. RESULTS: included later...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bacterial Infections and Vaccines
Share to Vaccine Coverage and Hesitancy
Share to Virology and Viral Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31971677
DOI: 10.1056/nejmoa1900236

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Meningococcal B Vaccine and Meningococcal Carriage in Adolescents in AustraliaPMID 31971677Read ↗

Meningococcal carriage in Dutch adolescents and young adults; a cross-sectional and longitudinal cohort studySemantic proximity Read ↗

Meningococcal Carriage among Adolescents after Mass Meningococcal C Conjugate Vaccination Campaigns in Salvador, Brazil.Semantic proximity Read ↗

Meningococcal carriage among a university student population - United States, 2015.Semantic proximity Read ↗

Potential impact of the bivalent rLP2086 vaccine on<i>Neisseria meningitidis</i>carriage and invasive serogroup B diseaseSemantic proximity Read ↗

From research to licensure and beyond: clinical development of MenB-FHbp, a broadly protective meningococcal B vaccineSemantic proximity Read ↗

Looking beyond meningococcal B with the 4CMenB vaccine: the Neisseria effectSemantic proximity Read ↗

The Diversity of Meningococcal Carriage Across the African Meningitis Belt and the Impact of Vaccination With a Group A Meningococcal Conjugate Vaccine.Semantic proximity Read ↗

Carriage of<i>Neisseria meningitidis</i>in Europe: a review of studies undertaken in the regionSemantic proximity Read ↗

Limited Impact of Adolescent Meningococcal ACWY Vaccination on Neisseria meningitidis Serogroup W Carriage in University Students.Semantic proximity Read ↗

Genetic Diversity of Meningococcal Serogroup B Vaccine Antigens among Carriage Isolates Collected from Students at Three Universities in the United States, 2015-2016.Semantic proximity Read ↗

Impact of MenBvac, an outer membrane vesicle (OMV) vaccine, on the meningococcal carriageSemantic proximity Read ↗

Meningococcal carriage among high school and university students in Gondar, Northwestern Ethiopia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.